Corient Private Wealth LLC Sells 11,905 Shares of The Ensign Group, Inc. $ENSG

Corient Private Wealth LLC trimmed its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 51.3% in the fourth quarter, HoldingsChannel reports. The firm owned 11,302 shares of the company’s stock after selling 11,905 shares during the period. Corient Private Wealth LLC’s holdings in The Ensign Group were worth $1,969,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of The Ensign Group by 9.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after buying an additional 14,590 shares during the period. Geneos Wealth Management Inc. raised its stake in The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock worth $50,000 after buying an additional 230 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in The Ensign Group by 65.9% in the second quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock worth $83,000 after acquiring an additional 213 shares in the last quarter. Amundi boosted its holdings in The Ensign Group by 480,216.7% in the second quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after acquiring an additional 57,626 shares in the last quarter. Finally, Brown Advisory Inc. grew its stake in The Ensign Group by 26.1% in the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after acquiring an additional 421 shares during the period. 96.12% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on ENSG shares. Royal Bank Of Canada restated an “outperform” rating on shares of The Ensign Group in a report on Tuesday, June 9th. Zacks Research cut The Ensign Group from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Weiss Ratings downgraded shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Finally, Wall Street Zen upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $216.75.

The Ensign Group Price Performance

Shares of NASDAQ ENSG opened at $158.19 on Tuesday. The stock has a market cap of $9.24 billion, a price-to-earnings ratio of 25.76, a PEG ratio of 1.59 and a beta of 0.68. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56. The Ensign Group, Inc. has a fifty-two week low of $134.79 and a fifty-two week high of $218.00. The firm’s 50-day simple moving average is $170.85 and its 200 day simple moving average is $184.92.

The Ensign Group (NASDAQ:ENSG) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.85 EPS for the quarter, topping the consensus estimate of $1.79 by $0.06. The Ensign Group had a return on equity of 16.78% and a net margin of 6.89%.The firm had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.40 billion. During the same period in the prior year, the business posted $1.52 earnings per share. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. As a group, research analysts anticipate that The Ensign Group, Inc. will post 6.82 earnings per share for the current fiscal year.

The Ensign Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a $0.065 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $0.26 annualized dividend and a dividend yield of 0.2%. The Ensign Group’s dividend payout ratio is presently 4.23%.

Insider Buying and Selling at The Ensign Group

In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of $199.97, for a total transaction of $78,388.24. Following the transaction, the director owned 9,295 shares of the company’s stock, valued at $1,858,721.15. This trade represents a 4.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total value of $114,996.00. Following the completion of the transaction, the director directly owned 21,352 shares in the company, valued at approximately $3,507,706.56. This represents a 3.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 2,592 shares of company stock valued at $478,246. Company insiders own 4.00% of the company’s stock.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.